Overview
Investors searching USX vs INJ usually want a clear market-cap and momentum snapshot. USX prints $1,882.43 (+0.00%) while Injective is at $5.13 (+3.91%), with volume edge currently on Injective.
Quick winners
Full comparison
| Metric | USX | INJ |
|---|---|---|
| Price | $1,882.43 | $5.13 |
| Market Cap | $516.56M | $490.41M |
| FDV | — | — |
| Volume 24h | $1.03M | $2.59M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 97.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USX | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.00% | +3.91% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USX | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (58.20 vs 48.70) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | USX | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USX
Injective
Pros and cons
Pros of USX
- USX has an established coin page footprint on PEPS for continuous monitoring.
- Market-cap scale on USX may dampen some idiosyncratic shocks versus smaller peers.
- Higher ranking for USX can translate into tighter spreads on major venues.
Cons of USX
- When dominance narratives fade, USX can lag hotter rotation names.
- Regulatory or macro headlines can hit USX harder simply because it is more visible.
- Crowded positioning around USX sometimes amplifies squeeze or flush risk.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Diversifying versus USX with Injective can change portfolio factor exposure.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Trend failures on Injective often travel faster than on more established assets.
- Relative underperformance versus USX can persist through entire market regimes.
Which looks stronger right now?
If you weight capitalization and liquidity, USX looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
In about three hundred words of context: USX (USX) trades near $1,882.43 with a +0.00% day move, while Injective (INJ) is around $5.13 (+3.91%). Volume leadership currently sits with Injective, and market-cap leadership with USX. Technical trend labels read bearish vs neutral, with RSI near 49.02/49.29. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, USX or Injective?
“Better” depends on horizon and risk. USX leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USX or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USX and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.